JAMA FEBRUARY 08, 2006

Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer/Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial

Prentice RL, Caan B, Chlebowski RT, Howard BV, et al.

Bottom Line

The Women's Health Initiative Dietary Modification trial found that a low-fat dietary pattern, emphasizing increased intake of vegetables, fruits, and grains, did not significantly reduce the incidence of breast cancer, colorectal cancer, or coronary heart disease in postmenopausal women over a median follow-up of 8.1 years.

Key Findings

1. During the 8.1-year median follow-up, the incidence of invasive breast cancer was 3.35% in the intervention group compared to 3.66% in the comparison group (HR 0.91; 95% CI, 0.83-1.01; P=0.07), a non-significant reduction.

2. The incidence of coronary heart disease (CHD) was 0.63% per year in the intervention group versus 0.65% in the comparison group (HR 0.97; 95% CI, 0.90-1.06), showing no significant benefit for cardiovascular outcomes.

3. Colorectal cancer incidence did not differ significantly between groups (HR 1.08; 95% CI, 0.90-1.29).

4. Long-term follow-up (median 19.6 years) in secondary analyses indicated a statistically significant reduction in breast cancer-followed-by-death (HR 0.79; 95% CI, 0.64-0.97) and all-cause mortality after breast cancer diagnosis, despite the lack of initial impact on disease incidence.

5. The intervention resulted in modest, statistically significant reductions in LDL cholesterol and diastolic blood pressure, but no meaningful changes in HDL, triglycerides, or fasting glucose.

Study Design

Design

RCT

Open-Label

Sample

48,835

Patients

Duration

8.1 yr

Median

Setting

Multicenter, US

Population Postmenopausal women aged 50-79 years without prior breast cancer

Intervention Low-fat dietary pattern (target 20% of energy from fat) with increased intake of vegetables, fruits, and grains

Comparator Usual dietary pattern

Outcome Incidence of invasive breast cancer and colorectal cancer

Study Limitations

• Participants in the intervention group did not fully achieve the ambitious target of reducing fat intake to 20% of energy, only reaching approximately 29%, which may have attenuated potential benefits.

• The study design relied on self-reported dietary intake, which is prone to recall bias and social desirability bias.

• The intervention focused broadly on a low-fat pattern rather than specific types of fats (e.g., polyunsaturated vs. saturated), potentially obscuring the benefits of healthier fat sources.

• As a large, multicenter behavioral intervention, adherence was challenging, and the difference in dietary intake between the intervention and control groups narrowed over time.

Clinical Significance

The study suggests that a general reduction in total dietary fat, without more focused emphasis on specific macronutrient qualities or caloric restriction, is insufficient to significantly reduce the incidence of breast or colorectal cancer and coronary heart disease in postmenopausal women. However, it highlights the potential for sustained healthy dietary patterns to influence long-term mortality outcomes after breast cancer diagnosis.

Historical Context

Initiated in 1993, the WHI Dietary Modification trial was a landmark NIH-funded study designed to test the widely held hypothesis from observational studies that lowering dietary fat intake would significantly reduce the risk of common chronic diseases in aging women, at a time when 'low-fat' was the prevailing public health paradigm for healthy eating.

Guided Discussion

High-yield insights from every perspective

Med Student

Medical Student

What is the hypothesized biological mechanism by which a low-fat diet was originally thought to reduce the risk of breast cancer in postmenopausal women?

Key Response

In postmenopausal women, the primary source of circulating estrogen is the aromatization of androgens in adipose tissue. A low-fat diet was hypothesized to reduce breast cancer risk by decreasing adiposity and, consequently, lowering serum estrogen levels, which are known to promote the growth of hormone-sensitive breast tissues.

Resident

The WHI study failed to show a significant reduction in coronary heart disease (CHD) with a low-fat diet. Based on the study's macronutrient shifts, what clinical factor might have neutralized the potential benefits of reduced saturated fat intake?

Key Response

In the intervention group, the reduction in total and saturated fat was largely replaced by an increase in carbohydrates (grains). High carbohydrate intake, particularly refined grains, can lead to increased triglyceride levels and decreased HDL-C, potentially counteracting the cardiovascular benefits achieved by lowering LDL-C through fat reduction.

Fellow

Despite the non-significant primary outcome for breast cancer, the WHI trial noted a non-significant 15% lower risk (HR 0.85) in women with the highest baseline fat intake who achieved the greatest reduction. How does this finding impact the interpretation of 'nutritional dose-response' in oncology trials?

Key Response

This suggests that the 'dose' of dietary intervention (the magnitude of fat reduction) may be a critical threshold for clinical benefit. If the population's baseline fat intake is already moderate or if the reduction achieved is insufficient, the study may be underpowered to detect an effect, implying that future trials may need to target specific high-risk/high-intake subgroups.

Attending

The WHI Dietary Modification trial is often cited as evidence that 'low-fat diets don't work.' How should an attending physician frame these results when teaching the evolution of the 'diet-heart hypothesis' and current Mediterranean-style dietary recommendations?

Key Response

The WHI trial demonstrated that focusing solely on 'total fat' reduction without specifying fat quality (e.g., replacing saturated fats with polyunsaturated fats rather than carbohydrates) is ineffective. This result catalyzed the clinical shift away from 'low-fat' toward 'healthy-fat' patterns, such as the Mediterranean diet, which emphasizes the type of fat over the quantity.

Scholarly Review

Critical appraisal through the lens of expert reviewers and guideline development

PhD

Critique the impact of 'dietary convergence' in the WHI trial and how the change in fat intake in the control group affects the statistical power and the Hazard Ratio (HR) interpretation.

Key Response

Dietary convergence occurs when the intervention group fails to meet targets (adherence) while the control group adopts healthier habits (contamination). In WHI, the difference in fat intake between groups narrowed to only ~8% by year 6. This reduces the effect size (moves the HR toward 1.0) and increases the risk of a Type II error, necessitating much larger cohorts or longer follow-ups to detect significant differences.

Journal Editor

As a reviewer, how would you evaluate the reliability of the Food Frequency Questionnaire (FFQ) data used in the WHI trial, and what are the implications of 'social desirability bias' on the study's internal validity?

Key Response

Self-reported dietary data via FFQs are prone to systematic measurement error. Social desirability bias often leads participants in the intervention arm to over-report fruit/vegetable intake and under-report fat intake. If the reported 10.7% difference in fat intake was actually smaller due to reporting bias, the study essentially tested a much weaker intervention than documented, fundamentally limiting its ability to reject the null hypothesis.

Guideline Committee

The 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease recommend a diet emphasizing vegetables, fruits, and legumes while limiting saturated fats, but do not strictly mandate a 'low-fat' percentage. How did the WHI results influence this shift from 'nutrient-based' to 'pattern-based' recommendations?

Key Response

The WHI trial provided high-quality RCT evidence that a 20% fat-target nutrient-based approach did not reduce CHD events (HR 0.98). Consequently, guideline committees shifted toward 'Whole Dietary Patterns' (e.g., DASH, Mediterranean) which focus on the food matrix and fat quality (favoring MUFAs/PUFAs over carbohydrates), rather than a quantitative restriction of total fat which often leads to unintended high-glycemic carbohydrate substitution.

Clinical Landscape

Noteworthy Related Trials

2006

Women's Health Initiative Dietary Modification Trial

n = 48,835 · JAMA

Tested

Low-fat dietary pattern

Population

Postmenopausal women

Comparator

Usual diet

Endpoint

Invasive breast cancer

Key result: The low-fat dietary pattern intervention did not result in a statistically significant reduction in invasive breast cancer incidence over 8.1 years.

2006

Women's Health Initiative Randomized Controlled Dietary Modification Trial: Cardiovascular Disease

n = 48,835 · JAMA

Tested

Low-fat dietary pattern

Population

Postmenopausal women

Comparator

Usual diet

Endpoint

Coronary heart disease

Key result: Reducing total fat intake did not significantly reduce the risk of coronary heart disease or stroke in postmenopausal women.

2013

PREDIMED Study

n = 7,447 · NEJM

Tested

Mediterranean diet supplemented with extra-virgin olive oil or nuts

Population

Older adults at high cardiovascular risk

Comparator

Reduced-fat diet

Endpoint

Major cardiovascular events

Key result: A Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced the incidence of major cardiovascular events by approximately 30%.

Tailored to your role

Want this tailored to you?

Add your specialty or training stage to get role-specific takeaways and more questions.

Personalize this analysis